RecruitingPhase 3NCT06259097

Different Medications to Induce Labor

Misoprostol Versus Pitocin for Induction of Labor in Patients With BMI > 30: A Randomized Controlled Trial

Sponsor

Icahn School of Medicine at Mount Sinai

Enrollment

300 participants

Start Date

Jul 2, 2024

Study Type

INTERVENTIONAL

Conditions

Pregnancy Labor

Summary

This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Misoprostol and a drug called Pitocin for people with labor and pregnancy. The study is currently recruiting participants at 2 locations. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.